A carregar...
Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19
A novel coronavirus, later named SARS-CoV-2, was first reported in China in December 2019 and subsequently widely identified in the United States, Japan, South Korea, France, India, and other countries. The disease caused by SARS-CoV-2 infection was called COVID-19. The high fatality and morbidity r...
Na minha lista:
| Publicado no: | Arch Pharm Res |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pharmaceutical Society of Korea
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395211/ https://ncbi.nlm.nih.gov/pubmed/32740801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12272-020-01258-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|